Lam Research Corporation $LRCX Shares Sold by Arvest Bank Trust Division

Arvest Bank Trust Division lowered its holdings in shares of Lam Research Corporation (NASDAQ:LRCX) by 27.6% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 125,434 shares of the semiconductor company’s stock after selling 47,928 shares during the period. Arvest Bank Trust Division’s holdings in Lam Research were worth $12,210,000 as of its most recent SEC filing.

Other institutional investors also recently bought and sold shares of the company. Brighton Jones LLC lifted its position in Lam Research by 1,032.4% during the 4th quarter. Brighton Jones LLC now owns 14,189 shares of the semiconductor company’s stock worth $1,025,000 after acquiring an additional 12,936 shares during the period. Mutual of America Capital Management LLC purchased a new stake in shares of Lam Research during the first quarter worth approximately $13,345,000. Stephens Inc. AR lifted its holdings in shares of Lam Research by 55.0% during the first quarter. Stephens Inc. AR now owns 9,603 shares of the semiconductor company’s stock worth $698,000 after purchasing an additional 3,409 shares during the period. CWM LLC grew its position in Lam Research by 32.0% in the 1st quarter. CWM LLC now owns 66,123 shares of the semiconductor company’s stock valued at $4,807,000 after buying an additional 16,028 shares during the last quarter. Finally, Edgestream Partners L.P. increased its stake in Lam Research by 29.0% in the 1st quarter. Edgestream Partners L.P. now owns 4,168 shares of the semiconductor company’s stock valued at $303,000 after buying an additional 938 shares during the period. 84.61% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Lam Research

In other Lam Research news, Director Bethany Mayer sold 1,298 shares of the stock in a transaction on Monday, November 3rd. The stock was sold at an average price of $159.99, for a total transaction of $207,667.02. Following the sale, the director owned 1,652 shares in the company, valued at approximately $264,303.48. This represents a 44.00% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Ava Harter sold 9,010 shares of the business’s stock in a transaction on Monday, October 27th. The stock was sold at an average price of $157.47, for a total value of $1,418,804.70. Following the completion of the transaction, the insider directly owned 56,786 shares of the company’s stock, valued at approximately $8,942,091.42. This trade represents a 13.69% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last 90 days, insiders have sold 62,528 shares of company stock valued at $8,880,448. 0.31% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on LRCX. Citigroup lifted their target price on shares of Lam Research from $175.00 to $190.00 and gave the company a “buy” rating in a report on Tuesday. BNP Paribas Exane lifted their price objective on Lam Research from $80.00 to $140.00 and gave the company a “neutral” rating in a report on Thursday, October 23rd. Weiss Ratings reiterated a “buy (b-)” rating on shares of Lam Research in a research report on Wednesday, November 5th. Needham & Company LLC raised their price target on Lam Research from $150.00 to $160.00 and gave the company a “buy” rating in a report on Thursday, October 23rd. Finally, Wells Fargo & Company upped their price objective on Lam Research from $135.00 to $145.00 and gave the stock an “equal weight” rating in a report on Thursday, October 23rd. One analyst has rated the stock with a Strong Buy rating, twenty-six have issued a Buy rating and nine have given a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $149.04.

Lam Research Stock Down 5.0%

LRCX opened at $153.32 on Friday. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.60 and a current ratio of 2.21. The company has a market cap of $192.57 billion, a price-to-earnings ratio of 33.77, a PEG ratio of 1.68 and a beta of 1.87. Lam Research Corporation has a one year low of $56.32 and a one year high of $167.15. The business’s fifty day moving average is $139.84 and its two-hundred day moving average is $108.87.

Lam Research (NASDAQ:LRCX) last released its quarterly earnings results on Wednesday, October 22nd. The semiconductor company reported $1.26 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.22 by $0.04. The business had revenue of $5.32 billion during the quarter, compared to the consensus estimate of $5.23 billion. Lam Research had a return on equity of 60.60% and a net margin of 29.66%.The business’s revenue was up 27.7% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.86 EPS. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. Analysts anticipate that Lam Research Corporation will post 3.71 EPS for the current fiscal year.

Lam Research Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 7th. Investors of record on Wednesday, December 3rd will be given a dividend of $0.26 per share. This represents a $1.04 annualized dividend and a dividend yield of 0.7%. The ex-dividend date is Wednesday, December 3rd. Lam Research’s payout ratio is currently 22.91%.

About Lam Research

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.